Case File
efta-efta00659325DOJ Data Set 9OtherJeffrey Epstein Wordpress Blog 1 FREEMAN 11-15-2012
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00659325
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
Jeffrey Epstein Wordpress Blog 1 FREEMAN 11-15-2012
Jeffrey Epstein: Supporter of Medical Research
Jeffrey Epstein has had the privilege of providing support to a number of different medical research
projects over the years. A number of projects research cancer treatments or make use of more
technologically advanced methods for detecting and diagnosing cancer before it has a chance to advance.
Most of these mMedical research projects would not be able to continue or end-te-get off of the ground
without the funding and support from individual philanthropists such as Jeffrey Epstein.:
Melanoma Research Alliance
One program that Epstein and the Jeffrey Epstein VI Foundation have provided support for is the
Melanoma Research Alliance. The MRA-is-itself-anerganizatien-that provides funding to projects that
examine melanoma, a malignant form of skin cancer. MRA provides funds to projects that make advances
in the diagnosis, treatment and prevention of melanoma. The organization has granted around $38 million
to over 65 institutions and 134 programs since 2008.
MRA makes efficient use of any and all funding it receives. The support MRA gets is then passed on in
the form of grants and funding to research labs across the world. The organization does not need to use
funds to pay for an extensive administrative staff. Thanks to support from Epstein's foundation, MRA has
provided grants to the Ludwig Institute for Cancer Research, Georgetown University; and Rockefeller
University.
American Cancer Society
The Foundation has also funded teamed-up-with-the American Cancer Society to provide financial
€unding-and support to scientists making advances in research in circulating tumor cell technology. One
of the major issues doctors and medical researchers face in the treatment of cancer is that treatment is
often hishly toxic. Additionally, cancer cells are able to mutate to resist treatment. CTC technology is a
simple blood test that allows researchers to isolate and examine cancer cells.
CTC technology has already had a large impact on the treatment of cancer. It has identified over 1,200
genetic mutations that can cause cancer to date. With this knowledge, doctors and researchers have been
able to develop targeted therapies that have been incredibly effective at reducing tumors. With the blood
tests, doctors are also able to develop secondary and tertiary lines of treatment should the cancer cells
continue to mutate.
As a long time science philanthropist, Jeffrey Epstein is pleased to see funding go to ground-breaking
research. The Jeffrey Epstein VI Foundation has been at the forefront of medical research funding for
years. Without philanthropists like Epstein, medical research would not be able to grow and make the
strides it has.
EFTA00659325
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.